StockNews.com Lowers Oramed Pharmaceuticals (NASDAQ:ORMP) to Sell

StockNews.com downgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Get Rating) from a hold rating to a sell rating in a report published on Monday morning. A number of other research analysts also recently weighed in on ORMP. Canaccord Genuity Group downgraded Oramed Pharmaceuticals from a buy rating to a hold rating and dropped their price […]

Related Keywords

Nadav Kidron ,Yadin Rozov ,Oramed Pharmaceuticals ,Lindbrook Capital ,News Ratings For Oramed Pharmaceuticals Daily ,Cantor Fitzgerald ,Jpmorgan Chase Co ,Oramed Pharmaceuticals Inc ,Institutional Trading Of Oramed Pharmaceuticals ,Securities Exchange Commission ,Oramed Pharmaceuticals Price Performance ,Blackrock Inc ,Renaissance Technologies ,Millennium Management ,Canaccord Genuity Group ,Insider Transactions At Oramed Pharmaceuticals ,Get Rating ,Genuity Group ,Director Yadin Rozov ,Exchange Commission ,Oramed Pharmaceuticals Daily ,Nasdaq Ormp ,Formp ,Medical ,Downgrade ,Stocknews Com ,